A new way of targeting to treat coronary artery disease

Journal of Cardiovascular Medicine

Volumn 11, Issue 1, 2010, Pages 1-6

  Siu, David ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antiplatelet; Atherosclerosis; Targeting

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; ANTITHROMBOCYTIC AGENT; ARACHIDONATE 15 LIPOXYGENASE; BATROXOBIN; BETA INTERFERON; CAPTOPRIL; CLOPIDOGREL; CURCUMIN; DEXTROMETHORPHAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; GARLIC EXTRACT; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PEONOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBUCOL SUCCINATE; QUERCETIN; TESTOSTERONE;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; GARLIC; GENETICS; HUMAN; INFLAMMATION; NONHUMAN; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; HUMANS; IMMUNOCONJUGATES; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME;

EID: 74249093346     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32832e0af3     Document Type: Review

References (34)

1. Insull W Jr. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am J Med 2009; 122:S3-S14.
2. Chen Y, Wang J, Nie R, Zhou S. Endogenous pro-resolving and antiinflammatory lipid mediators: the new hope of atherosclerotic diseases. Med Hypotheses 2008; 71:237-240.
3. Cai XJ, Li CJ, Chen L, Rong YY, Zhang Y, Zhang M. A hypothesis: adiponectin mediates antiatherosclerosis via adventitia-AMPK-iNOS pathway. Med Hypotheses 2008; 70:1044-1047.
4. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS. Testosterone as a protective factor against atherosclerosis: immunomodulation and influence upon plaque development and stability. J Endocrinol 2003; 178:373-380.
5. Tang Y, Liu C, Li C, Li W. The effect of defibrase in prevention of experimental atherosclerosis in rabbits. Zhonghua Bing Li Xue Za Zhi 1999; 28:112-114.
6. Raicu M, Pojoga L, Simionescu N, Simionescu M. The effect of ACE inhibitors on atheroma formation is potentiated by association with a calcium channel blocker. A biochemical and ultrastructural study. J Submicrosc Cytol Pathol 1997; 29:317-328.
7. Liu SL, Li YH, Shi GY, Tang SH, Jiang SJ, Huang CW, et al. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice. Cardiovasc Res 2009; 82:161-169.
8. Li H, Dai M, Jia W. Paeonol attenuates high-fat-diet-induced atherosclerosis in rabbits by anti-inflammatory activity. Planta Med 2009; 75:7-11.
9. Cornicelli JA. 15-lipoxygenase inhibitors as antiatherosclerosis agents. IDrugs 1998; 1:206-213.
10. Yuan HY, Kuang SY, Zheng X, Ling HY, Yang YB, Yan PK, et al. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol Sin 2008; 29:555-563.
11. Zhang LN, Velichko S, Vincelette J, Fitch RM, Vergona R, Sullivan ME, et al. Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice. Atherosclerosis 2008; 197:204-211.
12. Kamada C, da Silva EL, Ohnishi-Kameyama M, Moon JH, Terao J. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic Res 2005; 39:185-194.
13. Tardif JC, Gré goire J, Lavoie MA, L'Allier PL. Vascular protectants for the treatment of atherosclerosis. Expert Rev Cardiovasc Ther 2003; 1:385-392.
14. Wakino S. Antiatherosclerotic effects of PPAR gamma ligands. Nippon Rinsho 2004; 62:180-186.
15. Orekhov AN, Tertov VV, Sobenin IA, Pivovarova EM. Direct antiatherosclerosis-related effects of garlic. Ann Med 1995; 27:63-65.
16. Ferguson AD, Dokainish H, Lakkis N. Aspirin and clopidogrel response variability: review of the published literature. Tex Heart Inst J 2008; 35:313-320.
17. Tourmousoglou CE, Rokkas CK. Clopidogrel and aspirin in cardiovascular medicine: responders or not - current best available evidence. Cardiovasc Hematol Agents Med Chem 2008; 6:312-322.
18. Winter JP, Juergens CP. The role of tirofiban in the management of coronary artery disease. Cardiovasc Hematol Disord Drug Targets 2008; 8:138-146.
19. Doo YC, Han SJ, Lee JH, Cho GY, Hong KS, Han KR, et al. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris. Am J Cardiol 2004; 93:554-558.
20. Ekmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost 2006; 12:163-168.
21. Yang YM, Lv XY, Huang WD, Xu ZR, Wu LJ. Study of androgen and atherosclerosis in old-age male. J Zhejiang Univ Sci B 2005; 6:931-935.
22. Huang J, Zhou D, Tian L, Wu H, Zhang J, Zhang S. The effect of batroxobin on atherosclerosis. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2003; 20:197-201.
23. Cornicelli JA, Trivedi BK. 15-lipoxygenase and its inhibition: a novel therapeutic target for vascular disease. Curr Pharm Des 1999; 5:11-20.
24. Kawai Y, Nishikawa T, Shiba Y, Saito S, Murota K, Shibata N, et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the antiatherosclerotic mechanism of dietary flavonoids. J Biol Chem 2008; 283:9424-9434.
25. Doggrell SA. Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth. Expert Opin Investig Drugs 2003; 12:1855-1859.
26. Li D, Chen K, Sinha N, Zhang X, Wang Y, Sinha AK, et al. The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation. Cardiovasc Res 2005; 65:907-912.
27. Gorinstein S, Jastrzebski Z, Namiesnik J, Leontowicz H, Leontowicz M, Trakhtenberg S. The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Mol Nutr Food Res 2007; 51:1365-1381.
28. Gonen A, Harats D, Rabinkov A, Miron T, Mirelman D, Wilchek M, et al. The antiatherogenic effect of allicin: possible mode of action. Pathobiology 2005; 72:325-334.
29. Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 2007; 115:3156-3164.
30. Berger PB. The thienopyridines in coronary artery disease. Curr Cardiol Rep 1999; 1:192-198.
31. Din JN, Fox KA. Clopidogrel in acute coronary heart disease. Am Heart Hosp J 2005; 3:234-242.
32. Gabriel HM, Oliveira EI. Role of abciximab in the treatment of coronary artery disease. Expert Opin Biol Ther 2006; 6:935-942.
33. Robbesyn F, Salvayre R, Negre-Salvayre A. Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 2004; 38:541-551.
34. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002; 1585:213-221.